[HTML][HTML] Multi‐disciplinary collaborative consensus guidance statement on the assessment and treatment of cardiovascular complications in patients with post‐acute …

JH Whiteson, A Azola, JT Barry, MN Bartels… - Pm & R, 2022 - ncbi.nlm.nih.gov
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus responsible for
coronavirus disease 2019 (COVID-19), has caused substantial mortality and morbidity …

Management of cardiovascular disease during coronavirus disease (COVID-19) pandemic

S Ganatra, SS Dani, S Shah, A Asnani… - Trends in cardiovascular …, 2020 - Elsevier
Patients with pre-existing cardiovascular disease and risk factors are more likely to
experience adverse outcomes associated with the novel coronavirus disease-2019 (COVID …

ESC guidance for the diagnosis and management of cardiovascular disease during the COVID-19 pandemic: part 2—care pathways, treatment, and follow-up

Cardiovascular Research, 2022 - academic.oup.com
Aims Since its emergence in early 2020, the novel severe acute respiratory syndrome
coronavirus 2 causing coronavirus disease 2019 (COVID-19) has reached pandemic levels …

Cardiovascular Complications in Coronavirus Disease 2019—Pathogenesis and Management

MI Restrepo, J Marin-Corral… - … in Respiratory and …, 2023 - thieme-connect.com
The coronavirus disease 2019 (COVID-19) pandemic has caused a devastating impact on
morbidity and mortality around the world. Severe acute respiratory syndrome-coronavirus-2 …

COVID-19 pandemic: cardiovascular complications and future implications

D Bandyopadhyay, T Akhtar, A Hajra, M Gupta… - American Journal of …, 2020 - Springer
Abstract Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2), is now a global pandemic with the highest number …

Challenge of post-COVID era: management of cardiovascular complications in asymptomatic carriers of SARS-CoV-2

S Gupta, A Mitra - Heart failure reviews, 2022 - Springer
Abstract Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2), a highly
pathogenic member of family coronaviridae, has caused an exponentially growing global …

Description and proposed management of the acute COVID-19 cardiovascular syndrome

NS Hendren, MH Drazner, B Bozkurt, LT Cooper Jr - Circulation, 2020 - Am Heart Assoc
Coronavirus disease 2019 (COVID-19) is a rapidly expanding global pandemic caused by
severe acute respiratory syndrome coronavirus 2, resulting in significant morbidity and …

Diagnosis and treatment of cardiovascular manifestations of COVID-19: A narrative review

E Bilehjani, S Fakhari, H Farzin, A Tajlil… - Acta …, 2024 - Taylor & Francis
Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) was the main pathogen in
the COVID-19 pandemic. This viral infection has been associated with several respiratory …

Corrigendum to: European Society of Cardiology guidance for the diagnosis and management of cardiovascular disease during the COVID-19 pandemic: part 1 …

C Baigent, S Windecker, D Andreini, E Arbelo… - European Heart …, 2021 - air.unimi.it
Aims: Since its emergence in early 2020, the novel severe acute respiratory syndrome
coronavirus 2 causing coronavirus disease 2019 (COVID-19) has reached pandemic levels …

Acute and post-acute COVID-19 cardiovascular complications: a comprehensive review

C Kole, Ε Stefanou, N Karvelas, D Schizas… - … drugs and therapy, 2023 - Springer
Abstract Purpose of Review The risk of cardiovascular complications due to SARS-CoV-2
are significantly increased within the first 6 months of the infection. Patients with COVID-19 …